Today: 9 June 2026
Analog Devices stock nears 52-week high as Barclays upgrade sharpens focus on earnings
14 February 2026
1 min read

Analog Devices stock nears 52-week high as Barclays upgrade sharpens focus on earnings

New York, Feb 13, 2026, 17:54 EST — After-hours

  • ADI climbed roughly 1.8% on Friday, finishing close to its recent peak.
  • Barclays bumped the stock up to Overweight and raised its price target to $375.
  • Next week brings Analog Devices’ quarterly results, and investors are bracing for the numbers.

Analog Devices finished Friday up roughly 1.8% at $337.10, with shares hanging around that price in after-hours trading. That move added to a recent rally driving the stock close to its latest high.

Timing is key here. Traders are scrambling to figure out the next move in the industrial chip cycle. Analog Devices, for its part, supplies factory and infrastructure clients—demand from those buyers can lurch with shifts in the broader economy.

The stock, ahead of next week’s earnings, is acting less like its own narrative and more like a macro barometer. If the numbers impress, the rally probably stretches further. But any hint of caution—especially now, with expectations up—can spark a swift pullback.

Barclays’ Tom O’Malley bumped Analog Devices up to Overweight from Equal Weight, hiking his target to $375, up from $315. O’Malley cited the company’s outsized industrial exposure—calling it “by far” the highest in the analog sector—and described Analog Devices as a “quality name to own” while PMI numbers rebound. TipRanks

The stock finished Friday roughly 2% under its 52-week peak of $343.96—set just the previous day—during a session that saw little movement in the broader market. Texas Instruments climbed, Broadcom slipped; chip stocks are back to being sorted into winners and laggards.

Barclays highlighted the sector’s standout profitability, noting gross margins hovering near 70%, with operating margins between 40% and 45%. For Analog Devices, the firm said GAAP inventory was about 130 days—well below the 180-day average among peers. According to Barclays, a pickup in communications demand tied to the cloud could further boost the outlook.

Analysts are looking for earnings of roughly $2.30 a share and revenue near $3.12 billion this quarter, according to a Nasdaq.com preview that pulled from consensus estimates. The question hanging in the air: does this point to a more widespread recovery, or has the market already factored in the bounce?

The stock dropped 1.7% in the previous session, then bounced back Friday. Shares haven’t exactly followed a straight path.

Even so, the bull thesis needs macro trends to cooperate. Should PMI numbers sputter, or if clients continue burning off inventory beyond what investors are counting on, orders could drag and it’s guidance—not this quarter’s results—that ends up hurting.

The next major event lands Feb. 18. That’s when Analog Devices drops its first-quarter fiscal 2026 numbers ahead of the U.S. open, with a conference call following later that morning. Industrial demand, communications momentum, and the pace of inventory normalization — investors will be listening for any shift in the company’s messaging.

Stock Market Today

  • Designer Brands (DBI) Beats Q1 Earnings and Revenue Estimates
    June 9, 2026, 10:04 AM EDT. Designer Brands (DBI) reported Q1 earnings of $0.07 per share, surpassing the Zacks estimate of $0.02 and reversing a year-ago loss of $0.26. Revenue hit $696.35 million, just above the $696 million consensus. The company delivered a 250% earnings surprise and has beaten EPS estimates in four consecutive quarters. Shares rose about 19.5% year-to-date, outpacing the S&P 500's 8.2% gain. Despite strong results, the stock holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market. The Retail - Apparel and Shoes sector ranks among the top three industries. Future stock performance will depend on management's outlook and upcoming earnings estimate revisions, with current consensus estimates at $0.30 EPS on $744 million revenue next quarter and $0.35 EPS on $2.91 billion revenue for the fiscal year.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Anglo American share price in focus before London open as De Beers sale, results loom
Previous Story

Anglo American share price in focus before London open as De Beers sale, results loom

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 14.02.2026

Go toTop